» Articles » PMID: 35130029

The Tuberculous Granuloma and Preexisting Immunity

Overview
Date 2022 Feb 7
PMID 35130029
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary granulomas are widely considered the epicenters of the immune response to (Mtb), the causative agent of tuberculosis (TB). Recent animal studies have revealed factors that either promote or restrict TB immunity within granulomas. These models, however, typically ignore the impact of preexisting immunity on cellular organization and function, an important consideration because most TB probably occurs through reinfection of previously exposed individuals. Human postmortem research from the pre-antibiotic era showed that infections in Mtb-naïve individuals (primary TB) versus those with prior Mtb exposure (postprimary TB) have distinct pathologic features. We review recent animal findings in TB granuloma biology, which largely reflect primary TB. We also discuss our current understanding of postprimary TB lesions, about which much less is known. Many knowledge gaps remain, particularly regarding how preexisting immunity shapes granuloma structure and local immune responses at Mtb infection sites.

Citing Articles

Diminished -specific T-cell Responses During Pregnancy in Women With HIV and Receiving Isoniazid Preventive Therapy.

Saha A, Escudero J, Layouni T, Mecha J, Maleche-Obimbo E, Matemo D Open Forum Infect Dis. 2025; 12(2):ofaf067.

PMID: 39981072 PMC: 11842132. DOI: 10.1093/ofid/ofaf067.


B cells in non-lymphoid tissues.

Samiea A, Celis G, Yadav R, Rodda L, Moreau J Nat Rev Immunol. 2025; .

PMID: 39910240 DOI: 10.1038/s41577-025-01137-6.


A brief overview of mathematical modeling of the within-host dynamics of Mycobacterium tuberculosis.

Chakraborty D, Batabyal S, Ganusov V Front Appl Math Stat. 2025; 10.

PMID: 39906541 PMC: 11793202. DOI: 10.3389/fams.2024.1355373.


Eosinophils Enhance Granuloma-Mediated Control of Persistent Salmonella Infection.

Monack D, Butler D, Luccia B, Vilches-Moure J Res Sq. 2025; .

PMID: 39801515 PMC: 11722553. DOI: 10.21203/rs.3.rs-5610725/v1.


How macrophage heterogeneity affects tuberculosis disease and therapy.

Russell D, Simwela N, Mattila J, Flynn J, Mwandumba H, Pisu D Nat Rev Immunol. 2025; .

PMID: 39774813 DOI: 10.1038/s41577-024-01124-3.